secwatch.observer — SEC 8-K summary
======================================

Issuer:     SEELOS THERAPEUTICS, INC. (—)
CIK:        0001017491
Form:       8-K
Filed at:   2023-11-03T23:59:59+00:00
Accession:  0001104659-23-114286
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Seelos receives Nasdaq notices for bid price and market value non-compliance
----------------------------------------------------------------------------

- Bid price below $1.00 for 30 consecutive days; compliance deadline April 29, 2024.
- Market value of listed securities below $35M for 32 consecutive days; deadline April 30, 2024.
- Company may effect a reverse stock split to cure deficiencies; no immediate trading impact.
- Failure to comply may lead to delisting; company may appeal Nasdaq's determination.
- Stock continues trading on Nasdaq Capital Market under symbol SEEL.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1017491/000110465923114286/0001104659-23-114286-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1017491/000110465923114286/tm2329801d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-114286

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer